Streetinsider.com After-Hours Movers 06/17: (RMBS) (KFY) (IR) Higher; (GNMK) (SFL) (RPRX) Lower (more...)

June 17, 2013 6:01 PM EDT
Ship Finance International Limited (NYSE: SFL) 5.4% LOWER; announced an underwritten public offering of 8,000,000 common shares. The common shares are being offered pursuant to the Company's effective shelf registration statement. The Company intends to use the net proceeds of this offering to invest in new assets within the shipping and offshore sectors and for general corporate purposes, including working capital.

GenMark Diagnostics (NASDAQ: GNMK) 3.4% LOWER; updated its annual revenue guidance for the year ending December 31, 2013. As a result of additional uncertainties relating to the future revenue contribution from its largest customer, together with persisting reimbursement and other challenges affecting the emerging pharmacogenomics market sector, the Company is updating its annual revenue guidance to approximately $30 million from its original estimate of approximately $35 million. The Wall Street consensus is $35.1 million

Rambus Inc. (Nasdaq: RMBS) 2.9% HIGHER; signed a license agreement with STMicroelectronics (NYSE: STM). Also, updated its revenue guidance for the quarter ending June 30, 2013, narrowing the range to $56 million to $58 million from the initial range of $53 million to $58 million. In addition, subsequent to the Hynix settlement announced last week, the Company will be reversing a prior accrual included in operating expenses, related to previously awarded costs of $8 million in litigation expenses.

Repros Therapeutics Inc. (Nasdaq: RPRX) 2% LOWER; commenced an underwritten public offering of up to 3,000,000 shares of its common stock. All of the shares in the offering are to be sold by Repros Therapeutics Inc.

Exact Sciences Corp. (NASDAQ: EXAS) 2% LOWER; announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares to be sold in the offering are to be sold by Exact.

Korn/Ferry Int'l (NYSE: KFY) 1.6% HIGHER; reported Q4 EPS of $0.32, $0.01 better than the analyst estimate of $0.31. Revenue for the quarter came in at $227.9 million versus the consensus estimate of $223.58 million. Korn/Ferry Int'l sees Q1 2013 revenue of $215-227 million, versus the consensus of $217.47 million

Valeant Pharmaceuticals (NYSE: VRX) 1% LOWER; filed a preliminary prospectus supplement to its effective shelf registration statement on Form S-3 and has today made a similar filing with securities regulatory authorities in each of the provinces of Canada in connection with a public offering of its common shares to raise gross proceeds of approximately $1.75 billion.

Ingersoll-Rand (NYSE: IR) 0.8% HIGHER; announced that Allegion plc filed a Form 10 Registration Statement with the U.S. Securities & Exchange Commission in connection with Ingersoll Rands previously announced plan to spin off its commercial and residential security businesses.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

After-Hours Movers, S3